跳至主要内容
临床试验/NL-OMON39512
NL-OMON39512招募中4 期

Intramuscular corticosteroid injection in hip osteoarthritis: a randomized controlled trial - HOCI study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 135 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
135

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. A diagnosis of hip OA according to the cinical ACR criteria, including radiologic evidence of OA (kellgren-lawrence grading greater or equal than 2)
  • 2. age > 40 years
  • 3. Symptomatic disease for at least 6 months prior to enrolment
  • 4. Persistent pain despite receiving normal pain medication (acetaminophen and/or NSAID) for at least 3 weeks. Pain severity (in rest or on walking) defined as a minimum score of 3 on the Numerical Rating Scale (NRS; 0-10 range)

排除标准

  • Local or systemic infection precluding injection, diabetes mellitus, systemic arthritis, allergy to corticosteroid agent, use of oral corticosteroids, coagulopathy, anticoagulant therapy (cumarin type), peptic ulcer, previous intra-articular steroid injection into the index hip in the past 6 months, radiographic signs of osteonecrosis, pregnancy, lactating women, participation in other medical trials and on the waiting list for a hip replacement surgery

研究者

相似试验